Searched for
ATORVASTATIN RECALL
Over 140,000 bottles of cholesterol-lowering drug recalled: Safety concerns with Atorvastatin calcium tabletsA major recall is underway for over 140,000 bottles of Atorvastatin Calcium Tablets. This popular cholesterol medication, the generic form ...- Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in USAs per the US Food and Drug Administration's latest Enforcement report, the Hyderabad-based drug major is voluntarily recalling the affecte...
- Sun Pharma, Dr Reddy's, Aurobindo recall products in the US marketAs per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, whi...
- Dr Reddy's recalls 2.36 lakh bottles of cholesterol lowering tablets from USA class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health c...
- Dr Reddy's recalls 80,000+ bottles of Atorvastatin from USThe product is being recalled through three separate letters to the drug regulator. Dr Reddy's officials were not immediately available for...
- Dr Reddy's recalls over 55K bottles of hypertension drug in USDr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets.
- Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US marketThe firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.
- Ranbaxy shares settle 1.51 per cent down; market capitalisation erodes by Rs 43 croreShares of Ranbaxy Laboratories today settled for the day with losses of 1.51 %, pursuant to which the market capitalisation eroded by Rs 43...
- Ranbaxy Laboratories recalls over 64,000 bottles Lipitor; stock slips over 3%The FDA declared a Class II recall, which signifies a remote chance of severe adverse consequences or death due to the product flaw.
- Major developments at Ranbaxy over the past decadeA series of revelations by Dinesh Thakur indicates that how troubles at Ranbaxy Laboratories were because of the fraudulent practices.
- Ranbaxy’s Q4 performance remains volatileThe company has only a 2% market share of atorvastatin, the generic of Lipitor; the market share eroded after the drug was recalled tempora...
- Pharma companies look to be in better shape in March quarterGrowth in the domestic pharma sector, which has recovered marginally from the December quarter, still remains disappointing.
- Ranbaxy can only sell US-made Lipitor copyThe US Food and Drug Administration has allowed Ranbaxy to manufacture generic Lipitor at Ohm Labs facility in the US for American market.
- Ranbaxy surprises street with Q4 loss of Rs 492 croreThe Gurgaon-based firm has provisioned Rs 186 crore to deal with the costs arising out of the product recall.
- Ranbaxy restarts generic Lipitor production for US marketPharma major Ranbaxy Laboratories restarts production of generic cholesterol lowering drug Atorvastatin as it looks to resume supplies to U...
- American consumers approach court to consider recall of Ranbaxy's generic drug lipitorLast November, Ranbaxy had effected a limited recall of 41 lots of the drug from US pharmacies as it feared some of its drugs may be contai...
- Q3 Earnings Preview: US market to help pharma put up healthy numbersThe weakening of the rupee during a good part of the quarter to December will also help boost export realisations.
- Ranbaxy recalls generic Lipitor from the US marketRanbaxy today said it is recalling its generic version of cholesterol-lowering drug Lipitor from US market leading to temporary disruption ...
- Ranbaxy shares down over 3% after drug recall in USShares of Ranbaxy today slumped over three per cent on the bourses after the company said it has recalled its cholesterol-lowering drug Ato...
- Dr Reddy's to contest Pfizer's patent suit over atorvastatinDrug maker Dr Reddy's Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer ove...
Load More
